Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 187

1.

Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.

Rajendran M, Nachbagauer R, Ermler ME, Bunduc P, Amanat F, Izikson R, Cox M, Palese P, Eichelberger M, Krammer F.

MBio. 2017 Mar 21;8(2). pii: e02281-16. doi: 10.1128/mBio.02281-16.

2.

Assessment of influenza A neuraminidase (subtype N1) potency by ELISA.

Wan H, Sultana I, Couzens LK, Mindaye S, Eichelberger MC.

J Virol Methods. 2017 Mar 10;244:23-28. doi: 10.1016/j.jviromet.2017.02.015. [Epub ahead of print]

3.

Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.

Wang X, Ilyushina NA, Lugovtsev VY, Bovin NV, Couzens LK, Gao J, Donnelly RP, Eichelberger MC, Wan H.

J Virol. 2017 Jan 3;91(2). pii: e01512-16. doi: 10.1128/JVI.01512-16.

PMID:
27807224
4.

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay.

Gao J, Couzens L, Eichelberger MC.

J Vis Exp. 2016 Sep 6;(115). doi: 10.3791/54573.

5.

Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib.

Sun C, Gao J, Couzens L, Tian X, Farooqui MZ, Eichelberger MC, Wiestner A.

JAMA Oncol. 2016 Dec 1;2(12):1656-1657. doi: 10.1001/jamaoncol.2016.2437. No abstract available.

PMID:
27533065
6.

Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season.

Petrie JG, Ohmit SE, Truscon R, Johnson E, Braun TM, Levine MZ, Eichelberger MC, Monto AS.

J Infect Dis. 2016 Oct 15;214(8):1142-9. doi: 10.1093/infdis/jiw105.

PMID:
27095420
7.

Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity.

Eichelberger MC, Couzens L, Gao Y, Levine M, Katz J, Wagner R, Thompson CI, Höschler K, Laurie K, Bai T, Engelhardt OG, Wood J; ELLA study participants..

Vaccine. 2016 Jan 20;34(4):458-65. doi: 10.1016/j.vaccine.2015.12.022.

8.

Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.

Jiang L, Fantoni G, Couzens L, Gao J, Plant E, Ye Z, Eichelberger MC, Wan H.

J Virol. 2015 Oct 14;90(1):117-28. doi: 10.1128/JVI.01756-15.

9.

Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.

Ampofo WK, Azziz-Baumgartner E, Bashir U, Cox NJ, Fasce R, Giovanni M, Grohmann G, Huang S, Katz J, Mironenko A, Mokhtari-Azad T, Sasono PM, Rahman M, Sawanpanyalert P, Siqueira M, Waddell AL, Waiboci L, Wood J, Zhang W, Ziegler T; WHO Writing Group..

Vaccine. 2015 Aug 26;33(36):4368-82. doi: 10.1016/j.vaccine.2015.06.090.

10.

A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells.

Simhadri VR, Dimitrova M, Mariano JL, Zenarruzabeitia O, Zhong W, Ozawa T, Muraguchi A, Kishi H, Eichelberger MC, Borrego F.

PLoS One. 2015 Apr 27;10(4):e0124677. doi: 10.1371/journal.pone.0124677.

11.

Evaluation of Epic® label-free technology to quantify functional recombinant hemagglutinin.

Jiang L, Eichelberger MC.

Biol Proced Online. 2015 Mar 9;17:7. doi: 10.1186/s12575-015-0019-5.

12.

Optimization of an enzyme-linked lectin assay suitable for rapid antigenic characterization of the neuraminidase of human influenza A(H3N2) viruses.

Westgeest KB, Bestebroer TM, Spronken MI, Gao J, Couzens L, Osterhaus AD, Eichelberger M, Fouchier RA, de Graaf M.

J Virol Methods. 2015 Jun 1;217:55-63. doi: 10.1016/j.jviromet.2015.02.014.

13.

Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers.

Wan H, Yang H, Shore DA, Garten RJ, Couzens L, Gao J, Jiang L, Carney PJ, Villanueva J, Stevens J, Eichelberger MC.

Nat Commun. 2015 Feb 10;6:6114. doi: 10.1038/ncomms7114.

14.

Management of patients during hunger strike and refeeding phase.

Eichelberger M, Joray ML, Perrig M, Bodmer M, Stanga Z.

Nutrition. 2014 Nov-Dec;30(11-12):1372-8. doi: 10.1016/j.nut.2014.04.007.

PMID:
25280415
15.

An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera.

Couzens L, Gao J, Westgeest K, Sandbulte M, Lugovtsev V, Fouchier R, Eichelberger M.

J Virol Methods. 2014 Dec 15;210:7-14. doi: 10.1016/j.jviromet.2014.09.003.

16.

Influenza neuraminidase as a vaccine antigen.

Eichelberger MC, Wan H.

Curr Top Microbiol Immunol. 2015;386:275-99. doi: 10.1007/82_2014_398. Review.

PMID:
25033754
17.

Analyzing swine sera for functional antibody titers against influenza A neuraminidase proteins using an enzyme-linked lectin assay (ELLA).

Sandbulte MR, Eichelberger MC.

Methods Mol Biol. 2014;1161:337-45. doi: 10.1007/978-1-4939-0758-8_28.

PMID:
24899442
18.

Pediatric inpatient humanitarian care in combat: Iraq and Afghanistan 2002 to 2012.

Edwards MJ, Lustik M, Burnett MW, Eichelberger M.

J Am Coll Surg. 2014 May;218(5):1018-23. doi: 10.1016/j.jamcollsurg.2013.12.050.

PMID:
24745567
19.

Stability of neuraminidase in inactivated influenza vaccines.

Sultana I, Yang K, Getie-Kebtie M, Couzens L, Markoff L, Alterman M, Eichelberger MC.

Vaccine. 2014 Apr 17;32(19):2225-30. doi: 10.1016/j.vaccine.2014.01.078.

PMID:
24613525
20.

Surgical interventions for pediatric blast injury: an analysis from Afghanistan and Iraq 2002 to 2010.

Edwards MJ, Lustik M, Carlson T, Tabak B, Farmer D, Edwards K, Eichelberger M.

J Trauma Acute Care Surg. 2014 Mar;76(3):854-8. doi: 10.1097/TA.0b013e3182aa2e66.

PMID:
24553560

Supplemental Content

Loading ...
Support Center